Cardiac contractility, chronotropy, and vasopressor effect (modulation via herbal constituents)

The term "Cardiac contractility/chronotropy/vasopressor effect via herbal constituents" does **not** refer to a single molecular target but rather describes a set of physiological processes—namely the forcefulness and rate of heart contraction as well as vascular tone—that can be modulated by various bioactive compounds found in medicinal plants. These processes are regulated at the molecular level by numerous targets including beta-adrenoceptors (β1-, β2-, α1-adrenoceptors), L-type calcium channels, potassium channels, sodium-potassium ATPase pumps, phosphodiesterases among others.[1][3][5] Herbal medicines such as hawthorn (*Crataegus* spp.), tetrandrine-containing plants (*Stephania tetrandra*), resveratrol-rich sources (*Vitis vinifera*), oxymatrine from *Sophora flavescens*, curcumin from turmeric (*Curcuma longa*), among others have demonstrated positive inotropic effects (increasing myocardial contractility), negative chronotropic actions (slowing heart rate), vasodilatory properties or antiarrhythmic activities through diverse mechanisms.[2][4][6] However, this entry is not appropriate as a canonical therapeutic target because it aggregates multiple distinct pharmacological endpoints under one label. **Note:** This is not an individual molecule/receptor but an umbrella term describing several related cardiovascular functions that can be influenced by different plant-derived compounds acting on various established molecular targets. For structured databases focused on drug-target relationships at the protein/gene level this should be flagged as incorrect/incomplete.[1][3]

Other names

Cardiac inotropy/chronotropy/vasopressor modulationModulation of cardiac function by herbal medicinesHerbal modulation of cardiovascular targets

Herbal constituents can modulate cardiac contractility, chronotropy, and vascular tone through several mechanisms including: - Calcium channel antagonism or agonism - Inhibition of phosphodiesterases leading to increased cAMP levels - Modulation of sodium-potassium ATPase activity - Antioxidant and anti-inflammatory effects at the cellular level - Effects on adrenergic receptors or autonomic signaling pathways